CBS 2019
CBSMD教育中心
English

科学研究

科研文章

荐读文献

Why NOBLE and EXCEL Are Consistent With Each Other and With Previous Trials Prasugrel versus clopidogrel in patients with acute coronary syndromes Positive remodeling at 3 year follow up is associated with plaque-free coronary wall segment at baseline: a serial IVUS study Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance Meta-Analysis of Comparison of 5-Year Outcomes of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Unprotected Left Main Coronary Artery in the Era of Drug-eluting Stents Two-year outcomes following unprotected left main stenting with first vs new-generation drug-eluting stents: the FINE registry. EuroIntervention. Active SB-P Versus Conventional Approach to the Protection of High-Risk Side Branches: The CIT-RESOLVE Trial Differential prognostic impact of treatment strategy among patients with left main versus non-left main bifurcation lesions undergoing percutaneous coronary intervention: results from the COBIS (Coronary Bifurcation Stenting) Registry II Noninvasive Imaging for the Evaluation of Diastolic Function: Promises Fulfilled Role of intravascular ultrasound in patients with acute myocardial infarction undergoing percutaneous coronary intervention
|<<... 109 110 111 112 113 114 115 ...>>|

Clinical Trial2016 Oct 11;68(15):1622-1632.

JOURNAL：J Am Coll Cardiol. Article Link

Percutaneous Intervention for Concurrent Chronic Total Occlusions in Patients With STEMI: The EXPLORE Trial

Henriques JP, Hoebers LP, EXPLORE Trial Investigators. Keywords: STEMI; CTO; non-infarct-related artery; left ventricular ejection fraction; left ventricular end diastolic volume; cardiac magnetic resonance

FULL TEXT PDF

>CBS CBS 2019

> CBS 2019

> CBS 2019 注册

> CBS 2019 会议日程

> CBS 2019 学术征集

> CBS 2019 热点

 CBSMD

> CBSMD 网站注册

> 教育中心

> 荐读文献

> Top 10 阅读文献

> 文献导读
CBS 2019 CBS 2019 主席团 教育中心 科研动态
Copyright ⓒ CBS MD Nanjing China. All rights reserved. 京ICP备16025898号-11
联系我们| Top